View of GLP-1 receptor agonists in the management of COVID-19 and long COVID for patients with underlying metabolic disorders

Return to Article Details GLP-1 receptor agonists in the management of COVID-19 and long COVID for patients with underlying metabolic disorders Download Download PDF